Australia, Jan. 29 -- Incyte Holdings Corp., owns the trademark (2492842) for 'MINJUVI' and 'TRIANGLE,FOLDED' till July 24, 2034.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of auto-immune disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders.], 16 [Printed matter; Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building.] and 44 [Providing medical information to healthcare providers and patients relating to oncological, viral, hematological, auto-immune, graft versus host, inflammatory, metabolic, myeloproliferative, skeletal or chondrocyte and dermatological disorders.]
Type of Mark: Figurative
Date of Acceptance: Oct. 29, 2024
Registration Advertised: Jan. 28
For further details contact Frances M. Jagla and other attorneys at Christensen O'Connor Johnson Kindness PLLC.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2492842.
Disclaimer: Curated by HT Syndication.
